Cyproheptadine Hydrochloride
21 NDCs across 11 manufacturers|21 Generic,0 Brand
Cyproheptadine Hydrochloride is used to treat blepharospasm, cluster headache, dyskinesias, nelson syndrome, spastic paraparesis and pruritus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982.
Cyproheptadine Hydrochloride is available as 21 NDCs from 11 manufacturers (21 generic, 0 brand), with NADAC prices from $0.07 to $0.09 per EA — a 39% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
21
21G / 0B
Manufacturers
11
competing in market
Price Spread
$0.07 – $0.09
per EA, 15 of 21 NDCs
7d Activity
avg +0.1% WoW · of 21 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Quagen Pharmaceuticals LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing CYPROHEPTADINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CYPROHEPTADINE 4 MG TABLET | $0.0945 per EA | — |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 4 MG TABLET | $0.0679 per EA | +0.37% |
CYPROHEPTADINE 2 MG/5 ML SYRUP | $0.0419 per ML | -0.64% |
CYPROHEPTADINE 2 MG/5 ML SOLN | $0.0419 per ML | -0.64% |
CYPROHEPTADINE 2 MG/5 ML SYRUP | $0.0419 per ML | -0.64% |
CYPROHEPTADINE 2 MG/5 ML SOLN | $0.0419 per ML | -0.64% |
CYPROHEPTADINE 2 MG/5 ML SOLN | $0.0412 per ML | — |
CYPROHEPTADINE 2 MG/5 ML SOLN | $0.0412 per ML | — |
Frequently Asked Questions
What is Cyproheptadine Hydrochloride used to treat?
Cyproheptadine Hydrochloride is used to treat blepharospasm, cluster headache, dyskinesias, nelson syndrome, spastic paraparesis and pruritus, per the National Library of Medicine's MED-RT classification.
When did Cyproheptadine Hydrochloride become available as a generic?
FDA approved the first generic Cyproheptadine Hydrochloride (ANDA) on Jan 1, 1982.
How many Cyproheptadine Hydrochloride products are on the market?
The Cyproheptadine Hydrochloride drug market contains 21 NDCs from 11 manufacturers — 21 generic and 0 brand products.
What is the price range for Cyproheptadine Hydrochloride?
NADAC reference prices for Cyproheptadine Hydrochloride range from $0.0679 to $0.0945 per EA — a 39% difference between cheapest and most expensive. 6 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Cyproheptadine Hydrochloride?
11 manufacturers list Cyproheptadine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Quagen Pharmaceuticals LLC (4), Rising Pharma Holdings Inc. (3), Ingenus Pharmaceuticals LLC (2), TruPharma LLC (2), Chartwell RX LLC (2).
How has the price of Cyproheptadine Hydrochloride changed recently?
Over the past 7 days, 14 Cyproheptadine Hydrochloride NDCs rose and 4 fell, with a market-wide average change of +0.1%.